Skip to main content
. 2019 Oct 31;10:2464. doi: 10.3389/fmicb.2019.02464

TABLE 3.

Occurrence of resistance-associated genes with premature stop codons in resistant or susceptible strains in the ReSeq data set.

Drug Res Sus Gene Prem. stop codons in res. strains Prem. stop codons in sus. strains p-value
RMP 771 2710 rpoC 3 1 0.011
rpoB 2 0 0.008
inhA 1 0 0.137
INH 1093 2420 kasA 3 0 0.01
ahpC 1 2 0.934
katG 13 0 < 1.0e−5
STM 728 1239 rpsL 1 0 0.192
gidB 42 40 0.006
embA 1 4 0.658
embR 3 4 0.021
EMB 466 3040 embC 1 4 0.658
embB 1 2 0.306
ubiA 1 0 0.011
PZA 325 2993 pncA 372 7 < 1.0e−5
panD 6 0.148
ETH 49 175 inhA 1 0 0.058
ethA 21 24 < 1.0e−5
CAP 116 1024 tlyA 2 2 0.008

Genes annotated with premature stop codons in the mutation library are shown in bold. It was tested whether genes with premature stop codons were equally distributed between the two phenotypic groups. This was tested using a χ2 test on a 2 × 2 matrix, and the p-value is given. p-value below the significance level 0.01. Res, population of resistant strains; Sus, population of susceptible strains. RMP, Rifampicin; INH, Isoniazid; STM, Streptomycin; EMB, Ethambutol; PZA, Pyrazinamide; ETH, Ethionamide; CAP, Capreomycin.